TY  - GEN
AU  - Miller,K D
AU  - O'Neill,A
AU  - Perez,E A
AU  - Seidman,A D
AU  - Sledge,G W
TI  - A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group
SN  - 1569-8041
PY  - 2012///0522
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Heart Diseases
KW  - chemically induced
KW  - Humans
KW  - Middle Aged
KW  - Paclitaxel
KW  - Pilot Projects
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1093/annonc/mdr344
ER  -